Patent 7329353 was granted and assigned to Amgen on February, 2008 by the United States Patent and Trademark Office.
The present invention is directed to a novel method of analysis of high molecular weight proteins. More specifically, it is directed to a novel reversed-phase LC/MS method of analysis of high molecular weight proteins including antibodies.